Literature DB >> 17105281

An efficient mammalian transfer RNA target for bleomycin.

Zhi-Fu Tao1, Kazuhide Konishi, Gérard Keith, Sidney M Hecht.   

Abstract

The antitumor antibiotic bleomycin has long been believed to exert its therapeutic effects at the level of DNA cleavage. Recently, evidence has been presented to suggest that RNA cleavage may also be important and that one or more transfer RNAs may be involved. To define those tRNAs that may represent important loci for the action of bleomycin, we have fractionated chicken liver tRNAs and identified those isoacceptors most susceptible to oxidative cleavage by Fe(II).BLM. Two chicken liver tRNAs, tRNA3Lys and tRNAPhe, were found to be cleaved with exceptional facility by Fe(II).BLM, and both were cleaved predominantly at U66. The cleavage of tRNA3Lys was shown to be minimally affected by physiological concentrations of Mg2+. Chicken liver tRNA3Lys is identical in sequence with human tRNA3Lys. These findings support a possible role for a critical tRNA such as tRNA3Lys in the mechanism by which bleomycin mediates its antitumor activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17105281     DOI: 10.1021/ja066187x

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  5 in total

Review 1.  Microbial natural products: molecular blueprints for antitumor drugs.

Authors:  Lesley-Ann Giddings; David J Newman
Journal:  J Ind Microbiol Biotechnol       Date:  2013-09-03       Impact factor: 3.346

2.  Carbohydrate dependent targeting of cancer cells by bleomycin-microbubble conjugates.

Authors:  Jean-Charles Chapuis; Ryan M Schmaltz; Krystal S Tsosie; Marek Belohlavek; Sidney M Hecht
Journal:  J Am Chem Soc       Date:  2009-02-25       Impact factor: 15.419

3.  Dynamics of bleomycin interaction with a strongly bound hairpin DNA substrate, and implications for cleavage of the bound DNA.

Authors:  Trevor C Bozeman; Rupesh Nanjunda; Chenhong Tang; Yang Liu; Zachary J Segerman; Paul A Zaleski; W David Wilson; Sidney M Hecht
Journal:  J Am Chem Soc       Date:  2012-10-22       Impact factor: 15.419

4.  Selective tumor cell targeting by the disaccharide moiety of bleomycin.

Authors:  Zhiqiang Yu; Ryan M Schmaltz; Trevor C Bozeman; Rakesh Paul; Michael J Rishel; Krystal S Tsosie; Sidney M Hecht
Journal:  J Am Chem Soc       Date:  2013-02-13       Impact factor: 15.419

5.  Inhibitory effect of (-)-epigallocatechin-3-gallate and bleomycin on human pancreatic cancer MiaPaca-2 cell growth.

Authors:  Sabrina Bimonte; Maddalena Leongito; Antonio Barbieri; Vitale Del Vecchio; Massimiliano Barbieri; Vittorio Albino; Mauro Piccirillo; Alfonso Amore; Raimondo Di Giacomo; Aurelio Nasto; Vincenza Granata; Antonella Petrillo; Claudio Arra; Francesco Izzo
Journal:  Infect Agent Cancer       Date:  2015-07-29       Impact factor: 2.965

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.